Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Motilal Oswal Securities Ltd.
$81.00
Provider: Spark Capital Advisors(India) Private Limited
$35.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sun Pharmaceutical Industries Ltd In Talks To Buy Sweden's Meda AB For $5-$6 Billion-Business Standard


Thursday, 30 May 2013 03:16pm EDT 

Business Standard reported that Sun Pharmaceutical Industries Ltd is in talks to buy Sweden's Meda AB for between $5 billion and $6 billion to boost its generics business in developed markets, two sources with direct knowledge of the process said. Meda makes speciality products, over-the-counter drugs and branded generics the same areas of focus as Sun. 

Company Quote

857.95
10.85 +1.28%
6:14am EDT